Approaches to memory loss in neuropsychiatric disorders
- PMID: 11291022
- DOI: 10.1053/scnp.2000.16528
Approaches to memory loss in neuropsychiatric disorders
Abstract
Many neuropsychiatric disorders affect memory. Brain regions important in the neuroanatomic substrate of memory include the hippocampus, and sections of the frontal, temporal, and parietal cortices and the thalamus. Acetylcholine and many other neurotransmitters and neuromodulators including dopamine, glutamate, GABA, the catecholamines, and estrogen modulate cognitive function. Treatment approaches to memory loss typically use Alzheimer's dementia as the template, and are discussed in this report.
Copyright 2000 by W.B. Saunders Company
Similar articles
-
Donepezil improved memory in multiple sclerosis in a randomized clinical trial.Neurology. 2005 May 24;64(10):1823; author reply 1823. doi: 10.1212/wnl.64.10.1823. Neurology. 2005. PMID: 15911833 No abstract available.
-
Pharmacologic approaches to cognitive deficits in Alzheimer's disease.J Clin Psychiatry. 1998;59 Suppl 9:22-7. J Clin Psychiatry. 1998. PMID: 9720483 Review.
-
Successful use of donepezil in treatment of cognitive impairment caused by maintenance electroconvulsive therapy: a case report.J ECT. 2009 Sep;25(3):216-8. doi: 10.1097/YCT.0b013e3181926ada. J ECT. 2009. PMID: 19190508
-
Newest developments in dementia treatment and prevention.Geriatr Nurs. 2001 Jul-Aug;22(4):216, 218. doi: 10.1067/mgn.2001.117920. Geriatr Nurs. 2001. PMID: 11505251 No abstract available.
-
Clinical inquiries. Does treatment with donepezil improve memory for patients with mild cognitive impairment?J Fam Pract. 2006 May;55(5):435-6. J Fam Pract. 2006. PMID: 16670040 Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical